Vitamin C for COVID-19, Stool Test for Colorectal Cancer Screening, USPSTF on Oral Health, and more
Editor’s Summary by Anthony Charles, MD, MPH, Associate Editor of JAMA, the Journal of the American Medical Association, for the November 14, 2023, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - November 14, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Surgery : Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS
Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 23, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Which combinations of medicines are best for the prevention and treatment of anaemia in people with cancer?
Cochrane has produced several systematic reviews of interventions that might help people suffering from anaemia. In this podcast, Claire Iannizzi talks with lead author Anne Adams, both from the University Hospital Cologne in Germany, about a review of intravenous, oral or no iron in combination with erythropoiesis-stimulating agents for cancer patients with anaemia, which was published for the first time in June 2022. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - September 23, 2022 Category: General Medicine Authors: Cochrane Source Type: podcasts
JAMA Otolaryngology –Head & Neck Surgery : Use of Tumor Bed Frozen Section to Assess Final Tumor Margin in Oral Cavity Carcinoma
Interview with Snehal G. Patel, MD, author of Use of Intraoperative Frozen Section to Assess Final Tumor Margin Status in Patients Undergoing Surgery for Oral Cavity Squamous Cell Carcinoma. Hosted by Paul C. Bryson, MD, MBA. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - August 4, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Otolaryngology –Head & Neck Surgery : Use of FDG-PET/CT to Predict Immunotherapy Treatment Response in Patients With OCSCC
Interview with Heather Jacene MD, and Jonathan D. Schoenfeld, MD, MPH, authors of Use of Fluoro-[F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers Hosted by Joseph P. Bradley, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 20, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Diabetes Core Update – November 2019
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - October 25, 2019 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Novel Oral HIF-2 Alpha Inhibitor PT2977
Toni Choueiri M.D. Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute/Brigham and Womens Hospital and the Jerome and Nancy Kohlberg Chair and Professor of Med...
Author: kidneycancer
Added: 04/17/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2019 Category: Cancer & Oncology Source Type: podcasts
Clinical Trial Spotlight_ Can Epigenetic Priming Improve Efficacy of Immunotherapy in NSCLC_ [360p]
Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve outcomes in patients who receive immunotherapy for advanced lung cancer.
Author: cancergrace
Added: 04/01/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 1, 2019 Category: Cancer & Oncology Source Type: podcasts
A First-in-Human Phase 1/2 Trial of the Oral HIF-2a Inhibitor PT2977 in Patients with Advanced RCC
Toni K. Choueiri, MD of Dana-Farber Cancer Institute, Boston, MA discusses A First-in-Human Phase 1/2 Trial of the Oral HIF-2a Inhibitor PT2977 in Patients with Advanced RCCat the Kidney Cancer Assoc...
Author: kidneycancer
Added: 03/31/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 31, 2019 Category: Cancer & Oncology Source Type: podcasts
Does the Specific EGFR Mutation Matter When Choosing an Oral EGFR Inhibitor_ [360p]
Drs. Leora Horn, Ben Solomon, & Jack West discuss the open question of whether there are clinically significant differences among leading EGFR tyrosine kinases based on the specific EGFR mutation to b...
Author: cancergrace
Added: 03/30/2019 (Source: Oncology Tube)
Source: Oncology Tube - March 30, 2019 Category: Cancer & Oncology Source Type: podcasts
A breakthrough for oral mucositis management with avisopasem manganese
Locally advanced head and neck cancer is treated with chemotherapy and radiation as standard, with an aim to cure the disease. Unfortunately, this therapy is associated with severe toxicity, primarily...
Author: VJOncology
Added: 08/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 6, 2018 Category: Cancer & Oncology Source Type: podcasts
A breakthrough for oral mucositis management with avisopasem manganese
Locally advanced head and neck cancer is treated with chemotherapy and radiation as standard, with an aim to cure the disease. Unfortunately, this therapy is associated with severe toxicity, primarily...
Author: VJHemOnc
Added: 08/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 6, 2018 Category: Cancer & Oncology Source Type: podcasts
The convenience of oral TKIs influences treatment decisions
Primo N. Lara, Jr., MD, explains the convenience factor of oral TKIs influences decisions related to advanced renal cell carcinoma (RCC) treatment
Author: obr
Added: 07/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 27, 2018 Category: Cancer & Oncology Source Type: podcasts
The convenience of oral TKIs impacts RCC treatment
David I. Quinn, MD, discusses whether the convenience factor of oral TKIs enters into the decision-making process when treating advanced renal cell carcinoma (RCC) patients
Author: obr
Added: 07/24/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 24, 2018 Category: Cancer & Oncology Source Type: podcasts
